Questions of fairness and anti-doping in US cycling: The contrasting experiences of professionals and amateurs

References

• Albert, L. (2003, December 19). Houseman tests positive and gets suspended. PinkBike. Retrieved from http://www.pinkbike.com/news/article1816.html
   Google Scholar
• Amos, A. (2007). Inadvertent doping and the WADA code. Bond Law Review, 19, 1–25. Retrieved from http://epublications.bond.edu.au/blr/vol19/iss1/1
   Google Scholar
• Backhouse, S.H., & McKenna, J. (2012). Reviewing coaches' knowledge, attitudes and beliefs regarding doping in sport. International Journal of Sports Science and Coaching, 7, 167–176
   Web of Science ®Google Scholar
• Backhouse, S., McKenna, J., Robinson, S., & Atkin, A. (2007). International literature review: Attitudes, behaviours, knowledge and education – Drugs in sport: Past, present and future. Report to the World Anti-Doping Agency (WADA)
   Google Scholar
• Beamish, R., & Ritchie, I. (2004). From chivalrous ‘brothers-in-arms’ to the eligible athlete changed principles and the IOC's banned substance list. International Review for the Sociology of Sport, 39, 355–371
   Google Scholar
• Beaudin, M. (2013, October 21). Is it medicine or dope? A cat. 4 vs. the USADA. Velo News. Retrieved from http://velonews.competitor.com/2013/10/news/is-this-man-a-doper_306150
   Google Scholar
• Bette, K.H. (2004). Biographical risks and doping. In Hoberman, J., & Møller, V. (Eds.), Doping and public policy (pp. 101–111). Odense: University Press of Southern Denmark
   Google Scholar
• Bilard, J., Ninot, G., & Hauw, D. (2011). Motives for illicit use of doping substances among athletes calling a national antidoping phone-help service: An exploratory study. Substance Use & Misuse, 46, 359–367
   PubMed Web of Science ®Google Scholar
• Bloodworth, A., & McNamee, M. (2010). Clean Olympians? Doping and anti-doping: The views of talented young British athletes. International Journal of Drug Policy, 21, 276–282
   PubMed Web of Science ®Google Scholar
• Brewer, B.D. (2002). Commercialization in professional cycling 1950–2001: Institutional transformations and the rationalization of “doping”. Sociology of Sport Journal, 19, 276–301
   Web of Science ®Google Scholar
• Burns, T. (2014, January 24). 16 Local groups join USA cycling's race clean program. Cyclingnews. Retrieved from http://www.cyclingnews.com/news/16-local-groups-join-usa-cyclings-raceclean-program
   Google Scholar
• CBS Sports (2007, September 20). Canadian cyclist Jeanson admits to doping. CBC. Retrieved from http://www.cbc.ca/sports/canadian-cyclist-jeanson-admits-to-doping-1.675372
   Google Scholar
• Christiansen, A.V. (2005). The legacy of Festina: Patterns of drug use in European cycling since 1998. Sport in History, 25, 497–514
   Google Scholar
• Christiansen, A.V. (2010). “We are not sportsmen, we are professionals”: Professionalism, doping and deviance in elite sport. International Journal of Sport Management and Marketing, 7, 91–103
   Google Scholar
• Cohen, P.A. (2009). American roulette—Contaminated dietary supplements. New England Journal of Medicine, 361, 1523–1525
   PubMed Web of Science ®Google Scholar
• Cohen, P.A., Travis, J.C., & Venhuis, B.J. (2013). A methamphetamine analog (N,α-diethyl-phenylethylamine) identified in a mainstream dietary supplement. Drug Testing and Analysis. doi:10.1002/dta.1578
   PubMed Web of Science ®Google Scholar
• Cox, T.W. (2014). International war against doping: Limiting the collateral damage from strict liability. The Vanderbilt Journal of Transnational Law, 47, 295
   Google Scholar
• Denham, B.E. (2011). When science, politics, and policy collide: On the regulation of anabolic-androgenic steroids, steroid precursors, and ‘dietary supplements’ in the United States. Journal of Sport & Social Issues, 35, 3–21
   Web of Science ®Google Scholar
• Dimeo, P. (2007). A history of drug use in sport, 1876–1976: Beyond good and evil. London and New York: Routledge
   Google Scholar
• Dreier, F. (2012, July 27). Wider testing reveals doping among amateur cyclists, too. New York Times. Retrieved from http://www.nytimes.com/2012/07/28/sports/cycling/doping-in-cycling-reaches-into-amateur-ranks.html?_r=0
   Google Scholar
• Fitch, K.D. (2013). Therapeutic use exemptions (TUEs) at the Olympic Games 1992–2012. British Journal of Sports Medicine, 47, 815–818
   PubMed Web of Science ®Google Scholar
• Ford, B. (2011, October 23). Joe Papp's long and winding road: Lower-tier pro's career, PED role touched some of cycling's biggest names. ESPN. Retrieved from http://espn.go.com/espn/otl/story/_/id/7132452/former-cyclist-joe-papp-gets-three-years-probation-ped-case
   Google Scholar
• Gleaves, J. (2010). No harm, no foul? Justifying bans on safe performance-enhancing drugs. Sport, Ethics and Philosophy, 4, 269–283
   Google Scholar
• Gleaves, J., Llewellyn, M., & Lehrbach, T. (2014). Before the rules were written: Navigating moral ambiguity in performance enhancement. Sport, Ethics and Philosophy, 8, 85–99
   Google Scholar
• Hamilton, T., & Coyle, D. (2012). The secret race: Inside the hidden world of the Tour de France: Doping, cover-ups and winning at all costs. London: Bantam
   Google Scholar
• Hanstad, D.V., & Waddington, I. (2009). Sport, health and drugs: A critical re-examination of some key issues and problems. Perspectives in Public Health, 129, 174–182
   PubMed Web of Science ®Google Scholar
• Henne, K., Koh, B., & McDermott, V. (2013). Coherence of drug policy in sports: Illicit inclusions and illegal inconsistencies. Performance Enhancement & Health, 2, 48–55
   Google Scholar
• Henning, A.D. (2013). (Self-)surveillance, anti-doping, and health in non-elite road running. Surveillance & Society, 11, 494–507
   Google Scholar
• Hoberman, J. (2003). ‘A pharmacy on wheels’: Doping and community cohesion among professional cyclists following the Tour de France Scandal of 1998. In V. Møller, & J. Nauright (Eds.), The essence of sport (pp. 107–128). Odense: University of Southern Denmark Press
   Google Scholar
• Hoberman, J. (2005). Testosterone dreams: Rejuvenation, aphrodisia, doping. Berkeley: University of California Press
   Google Scholar
• Hoff, D. (2012). Doping, risk and abuse: An interview study of elite athletes with a history of steroid use. Performance Enhancement & Health, 1, 61–65
   Google Scholar
• Huestis, M.A., Mazzoni, I., & Rabin, O. (2011). Cannabis in sport. Sports Medicine, 41, 949–966
   PubMed Web of Science ®Google Scholar
• Hunt, T.M., Dimeo, P., & Jedlicka, S.R. (2012). The historical roots of today's problems: A critical appraisal of the international anti-doping movement. Performance Enhancement & Health, 1, 55–60
   Google Scholar
• Kamber, M. (2011). Development of the role of National Anti-Doping Organisations in the fight against doping: From past to future. Forensic Science International, 213, 3–9
   PubMed Web of Science ®Google Scholar
• Kayser, B., & Broers, B. (2012). The Olympics and harm reduction. Harm Reduction Journal, 9, 1–9
   PubMed Web of Science ®Google Scholar
• Kayser, B., Mauron, A., & Miah, A. (2007). Current anti-doping policy: A critical appraisal. BMC Medical Ethics, 8, 2. doi:10.1186/1472-6939-8-2
   Google Scholar
• Knapp, G. (2004, July 29). Bergman sacked by Jelly Belly, may lose NRC points. Cycling News. Retrieved from http://autobus.cyclingnews.com/features/?id=2004/bergman_suspended
   Google Scholar
• Lamont-Mills, A., & Christensen, S. (2008). ‘I have never taken performance enhancing drugs and I never will’: Drug discourse in the Shane Warne case. Scandinavian Journal of Medicine & Science in Sports, 18, 250–258
   PubMed Web of Science ®Google Scholar
• Laure, P., & Reinsberger, H. (1995). Doping and high-level endurance walkers. Knowledge and representation of a prohibited practice. The Journal of Sports Medicine and Physical Fitness, 35, 228–231
   PubMed Web of Science ®Google Scholar
• Laurendeau, J., & Moroz, S. (2012). Morality in the mountains: Risk, responsibility, and neoliberalism in newspaper accounts of backcountry rescue. Communication & Sport, 1, 382–399
   Google Scholar
• Lentillon-Kaestner, V.V., & Carstairs, C.C. (2010). Doping use among young elite cyclists: A qualitative psychosociological approach. Scandinavian Journal of Medicine & Science in Sports, 20, 336–345
   PubMed Web of Science ®Google Scholar
• Lentillon-Kaestner, V.V., Hagger, M.S., & Hardcastle, S.S. (2012). Health and doping in elite-level cycling. Scandinavian Journal of Medicine & Science in Sports, 22, 596–606
   PubMed Web of Science ®Google Scholar
• Lopez, B. (2011). The invention of a ‘drug of mass destruction’: Deconstructing the EPO myth. Sport in History, 31, 84–109
   Google Scholar
• Lovett, I. (2012, October 17). ‘Tattooed guy’ was pivotal in Armstrong case. New York Times. Retrieved from http://www.nytimes.com/2012/10/18/sports/cycling/inquiry-into-kayle-leogrande-led-to-lance-armstrongs-eventual-fall.html?pagewanted=all&_r=0
   Google Scholar
• Lundby, C., Achman-Andersen, N.J., Thomsen, J.J., Norgaard, A.M., & Robach, P. (2008). Testing for recombinant human erythropoietin in urine: Problems associated with current anti-doping testing. Journal of Applied Physiology, 105, 417–419
   PubMed Web of Science ®Google Scholar
• Macur, J. (2004). Seeking her way out of infamy. New York Times. Retrieved from http://www.nytimes.com/2004/08/10/sports/olympics-seeking-her-way-out-of-infamy.html
   Google Scholar
• Martin, D.M., Baron, D.A., & Gold, M.S. (2006). A review of performance-enhancing drugs in professional sports and their spread to amateur athletics, adolescents, and other at-risk populations. Journal of Addictive Diseases, 25, 5–15
   Google Scholar
• Mazanov, J., Huybers, T., & Connor, J. (2011). Qualitative evidence of a primary intervention point for elite athlete doping. Journal of Science and Medicine in Sport, 14, 106–110
   PubMed Web of Science ®Google Scholar
• McDonald, M.G., & Birrell, S. (1999). Reading sport critically: A methodology for interrogating power. Sociology of Sport Journal, 16, 283–300
   Web of Science ®Google Scholar
• Miceli, A. (2013, May 15). Tour mum as WADA softens stance on marijuana. Golfweek
   Google Scholar
• Mignon, P. (2003). The Tour de France and the doping issue. The International Journal of the History of Sport, 20, 227–245
   Google Scholar
• Møller, V. (2006). Knud Enemark Jensen's death during the 1960 Rome Olympics: A search for truth? Sport in History 25, 452–471
   Google Scholar
• Møller, V. (2014). Who guards the guardians. The International Journal of the History of Sport 31, 934–950
   Web of Science ®Google Scholar
• Morente-Sánchez, J., & Zabala, M. (2013). Doping in sport: A review of elite athletes' attitudes, beliefs, and knowledge. Sports Medicine, 43, 395–411
   PubMed Web of Science ®Google Scholar
• North American Court of Arbitration (NACAS). (2003). Decision. Retrived from http://www.usada.org/testing/results/arbitration-decisions/
   Google Scholar
• Ntoumanis, N., Ng, J.Y.Y., Barkoukis, V., & Backhouse, S.H. (2013). A statistical synthesis of the literature on personal and situational variables that predict doping in physical activity settings. Technical report. Montreal: World Anti-Doping Agency
   Google Scholar
• Ntoumanis, N., Ng, J.Y.Y., Barkoukis, V., & Backhouse, S.H. (2014). Personal and psychosocial predictors of doping use in physical activity settings: A meta-analysis. Sports Medicine, 44, 1603–1624
   PubMed Web of Science ®Google Scholar
• Ohl, F., Fincoeur, B., Lentillon-Kaestner, V., Defrance, J., & Brissonneau, C. (2013). The socialization of young cyclists and the culture of doping. International Review for the Sociology of Sport, 1–18
   Google Scholar
• Outram, S.M., & Stewart, B. (2015). Condemning and condoning: Elite amateur cyclists' perspectives on drug use and professional cycling. International Journal of Drug Policy. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Overbye, M., Knudsen, M.L., & Pfister, G. (2013). To dope or not to dope: Elite athletes' perceptions of doping deterrents and incentives. Performance Enhancement & Health, 2, 119–134
   Google Scholar
• Overbye, M., & Wagner, U. (2013). Between medical treatment and performance enhancement: An investigation of how elite athletes experience therapeutic use exemptions. International Journal of Drug Policy, 24, 579–588
   PubMed Web of Science ®Google Scholar
• Petróczi, A., & Aidman, E. (2009). Measuring explicit attitude toward doping: Review of the psychometric properties of the Performance Enhancement Attitude Scale. Psychology of Sport and Exercise, 10, 390–396
   Web of Science ®Google Scholar
• Pitsch, W., Emrich, E., & Klein, M. (2007). Doping in elite sports in Germany: Results of a www survey. European Journal for Sport and Society, 4, 89–102
   Google Scholar
• Pluim, B. (2008). A doping sinner is not always a cheat. British Journal of Sports Medicine, 42, 549–550
   PubMed Web of Science ®Google Scholar
• Ramachandra, K., Narendranat, S., Somashekar, H.S., Patil, N.A., Reshma, S.R., & Veena, A. (2012). Drug abuse in sports. Journal of Pharmacy Research, 5, 593–603
   Google Scholar
• Rogers, N. (2010, November 25). Chuck Coyle blames doping suspension on former teammates. VeloNews. Retrieved from http://velonews.competitor.com/2010/11/news/chuck-coyle-blames-doping-suspension-on-former-teammates_150931
   Google Scholar
• Rogers, N. (2012, May 1). USADA: O'Neill a key player in O'Bee doping case. VeloNews. Retrieved from http://velonews.competitor.com/2010/10/news/usada-o%E2%80%99neill-a-key-player-in-obee-doping-case_145215
   Google Scholar
• Sas-Nowosielski, K., & Swiatkowska, L. (2008). Goal orientations and attitudes toward doping. International Journal of Sports Medicine, 29, 607–612
   PubMed Web of Science ®Google Scholar
• Sefiha, O. (2012). Bike racing, neutralization, and the social construction of performance-enhancing drug use. Contemporary Drug Problems, 39, 213–245
   Google Scholar
• Simon, R. (2004). Fair play: Sports, value and society. 2nd ed. Boulder, CO: Westview Press
   Google Scholar
• Sjöqvist, F., Garle, M., & Rane, A. (2008). Use of doping agents, particularly anabolic steroids, in sports and society. The Lancet, 371, 1872–1882
   PubMed Web of Science ®Google Scholar
• Smith, A.C., Stewart, B., Oliver-Bennetts, S., McDonald, S., Ingerson, L., Anderson, A. … Graetz, F. (2010). Contextual influences and athlete attitudes to drugs in sport. Sport Management Review, 13, 181–197
   Google Scholar
• Stewart, B., & Smith, A.C. (2008). Drug use in sport implications for public policy. Journal of Sport & Social Issues, 32, 278–298
   Web of Science ®Google Scholar
• Stokes, S. (2010, November 24). US Masters rider Neal Schubel suspended after EPO purchase and use. Velonation. Retrieved from http://www.velonation.com/News/ID/6478/US-Masters-rider-Neal-Schubel-suspended-after-EPO-purchase-and-use.aspx
   Google Scholar
• Straubel, M. (2008). International convention against doping in sport: Is it the missing link to USADA being a state actor and WADC coverages of US Pro athletes. Marqeutte Sports Law Review, 19, 63–89
   Google Scholar
• Strelan, P., & Boeckmann, R.J. (2006). Why drug testing in elite sport does not work: Perceptual deterrence theory and the role of personal moral beliefs. Journal of Applied Social Psychology 36, 2909–2934
   Web of Science ®Google Scholar
• Tilin, A. (2011). The doper next door: My strange and scandalous year on performance enhancing drugs. Berkeley, CA: Counterpoint
   Google Scholar
• Tsorbatzoudis, H., Rodafinos, A., Spiliopoulou, H., Barkoukis, V., & Lazuras, L. (2009). Determinants of doping intentions in sport. WADA final report.Salonika: Aristotle University of Thessaloniki
   Google Scholar
• USA Cycling (2004, March 25). USADA announces results of Sbeih hearing. Retrieved from http://www.usacycling.org/usada-announces-results-of-sbeih-hearing.htm
   Google Scholar
• USA Cycling (2006, February 16). USADA sanctions Uruguayan rider. Retrieved from http://www.usacycling.org/usada-sanctions-uruguayan-rider.htm
   Google Scholar
• USA Cycling (2010, September 9). Cycling athlete receives life-time ban for 2nd doping violation. Retrieved from http://www.usacycling.org/cycling-athlete-receives-life-time-ban-for-2nd-doping-violation.htm
   Google Scholar
• USA Cycling (2014, May 8). Masters cyclist, Robertson, accepts sanction for anti-doping violation. Retrieved from http://www.usacycling.org/masters-cyclist-robertson-accepts-sanction-for-anti-doping-violation.htm
   Google Scholar
• USADA (2003, September 29). U.S. cyclist Krause accepts provisional suspension from U.S. anti-doping agency for positive drug test. Retrieved from http://www.usada.org/u-s-cyclist-krause-accepts-provisional-suspension-from-u-s-anti-doping-agency-for-positive-drug-test/
   Google Scholar
• USADA (2012, August 24). Reasoned decision of the United States anti-doping agency on disqualification and ineligibility. Retrieved from http://cyclinginvestigation.usada.org/
   Google Scholar
• Vetteniemi, E. (2010). Runners, rumors, and reams of representations. Journal of Sport History, 37, 415–430
   Google Scholar
• WADA. (2013, May 13). WADA executive committee and foundation board approach final revision of 2015 code. Retrieved from https://www.wada-ama.org/en/media/news/2013-05/wada-executive-committee-and-foundation-board-approach-final-revision-of-2015
   Google Scholar
• Waddington, I. (2000). Sport, health and drugs: A critical sociological perspective. London: Spon
   Google Scholar
• Weislo, L. (2009, November 10). Williams admits to doping positive. Cyclingnews. Retrieved from http://www.cyclingnews.com/news/williams-admits-to-doping-positive
   Google Scholar
• Wiesing, U. (2011). Should performance-enhancing drugs in sport be legalized under medical supervision? Sports Medicine, 41, 167–176
   PubMed Web of Science ®Google Scholar
• World Anti-Doping Agency (WADA). (2009). World Anti-Doping Code. World Anti-Doping Agency. Retrieved from http://www.wadaama.org/en/World-Anti-Doping-Program/Sports-and-Anti-Doping-Organizations/The-Code/
   Google Scholar
• Yonamine, M., Garcia, P.R., & de Moraes Moreau, R.L. (2004). Non-intentional doping in sports. Sports Medicine, 34, 697–704
   PubMed Web of Science ®Google Scholar